ici 118551 has been researched along with Alzheimer Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Branca, C; Caccamo, A; Hartman, LK; Oddo, S; Wisely, EV | 1 |
| Lu, RC; Miao, D; Tan, L; Tian, Y; Wang, ND; Wang, XX; Yu, JT; Yu, NN | 1 |
| Cowburn, RF; Fowler, CJ; O'Neill, C; Ravid, R; Vestling, M; Winblad, B | 1 |
3 other study(ies) available for ici 118551 and Alzheimer Disease
| Article | Year |
|---|---|
Administration of a selective β2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer's disease.
Topics: Adrenergic beta-2 Receptor Antagonists; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cerebral Cortex; Cognition; Disease Models, Animal; Disease Progression; Female; Hippocampus; Male; Mice, Transgenic; Phosphorylation; Propanolamines; Receptors, Adrenergic, beta-2; tau Proteins | 2014 |
Blocking beta2-adrenergic receptor attenuates acute stress-induced amyloid beta peptides production.
Topics: Acute Disease; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alzheimer Disease; Amyloid beta-Peptides; Animals; Clenbuterol; Disease Models, Animal; Hippocampus; Male; Mice; Mice, Inbred C57BL; Peptide Fragments; Propanolamines; Proto-Oncogene Proteins c-fos; Random Allocation; Receptors, Adrenergic, beta-2; Restraint, Physical; RNA, Messenger; Stress, Psychological | 2010 |
Disrupted beta 1-adrenoceptor-G protein coupling in the temporal cortex of patients with Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Binding, Competitive; Female; GTP-Binding Proteins; Guanylyl Imidodiphosphate; Humans; Isoproterenol; Male; Middle Aged; Propanolamines; Protein Binding; Receptors, Adrenergic, beta; Signal Transduction; Synaptic Membranes; Temporal Lobe | 1993 |